Your browser doesn't support javascript.
loading
Leukemic cell line, KG-1 has a functional loss of hOGG1 enzyme due to a point mutation and 8-hydroxydeoxyguanosine can kill KG-1.
Hyun, J W; Choi, J Y; Zeng, H H; Lee, Y S; Kim, H S; Yoon, S H; Chung, M H.
Afiliación
  • Hyun JW; Department of Pharmacology, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul 110-744, Korea.
Oncogene ; 19(39): 4476-9, 2000 Sep 14.
Article en En | MEDLINE | ID: mdl-11002420
ABSTRACT
We tested the cytotoxic action of 8-hydroxyguanine (8ohG) by observing the viability of several leukemic cell lines (KG-1, U937, Jurkat and K 562) in the presence of 8-hydroxydeoxyguanosine (8ohdG), a nucleoside of 8ohG. It was found that 8ohdG showed cytotoxic action only to KG-1 and that only KG-1 showed a homozygous arginine 209 to glutamine mutation in the hOGG1 gene with an almost negligible hOGG1 enzyme activity. Possibly, the selective cytotoxicity in 8ohdG to KG-1 may be due to its low capacity to cope with an increase in the 8ohG level in DNA resulting from the incorporation of 8ohdG present in the culture media. The mutational impairment of hOGG1 in KG-1 is the first report in leukemic cell lines. Using KG-1 with impaired hOGG1, we demonstrated cytotoxicity of 8ohdG probably due to its incorporation into cellular DNA. This new property of KG-1 may allow it to serve as an useful tool for studies of OGG1, oxidative DNA damage and the cytotoxic action of 8ohG. Oncogene (2000) 19, 4476 - 4479.
Asunto(s)
Buscar en Google
Bases de datos: MEDLINE Asunto principal: Leucemia / Mutación Puntual / Desoxiguanosina / N-Glicosil Hidrolasas Límite: Humans Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2000 Tipo del documento: Article
Buscar en Google
Bases de datos: MEDLINE Asunto principal: Leucemia / Mutación Puntual / Desoxiguanosina / N-Glicosil Hidrolasas Límite: Humans Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2000 Tipo del documento: Article